27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.

RENE Insider Trading (ReNeuron Group)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): £87,550
Insider Selling (Last 12 Months): GBX 0

ReNeuron Group Insider Trading History Chart

This chart shows the insider buying and selling history at ReNeuron Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ReNeuron Group Share Price & Price History

Current Price: GBX 26.50
Price Change: +0.30 (1.20%)
As of 08/10/2022 01:00 AM ET

This chart shows the closing price history over time for RENE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

ReNeuron Group Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/12/2022Barbara StaehelinInsiderBuy127,000GBX 30£38,100
10/20/2021Barbara StaehelinInsiderBuy43,000GBX 115£49,450
See Full Table
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!

SEC Filings (Institutional Ownership Changes) for ReNeuron Group (LON:RENE)

ReNeuron Group logo
ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate that is in the partnering stage in china and outside china for treating stroke disability; and human retinal progenitor cell therapy that is in Phase I/IIa clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are in the pre-clinical stage, which are Nano-sized packages of information released by CTX cells. In addition, the company licenses ReNcell products. It has a collaboration agreement with University College London to conduct research into the generation of immune cells from induced pluripotent stem cells for anti-cancer cell therapies. ReNeuron Group plc was founded in 1997 and is headquartered in Pencoed, the United Kingdom.
Read More on ReNeuron Group

Today's Range

Now: GBX 26.50
Low: 26.01
High: 26.60

50 Day Range

MA: GBX 29.74
Low: 26.05
High: 34

52 Week Range

Now: GBX 26.50
Low: 25
High: 135

Volume

22,544 shs

Average Volume

270,949 shs

Market Capitalization

£15.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of ReNeuron Group?

ReNeuron Group's top insider investors include:
  1. Barbara Staehelin (Insider)
Learn More about top insider investors at ReNeuron Group.
A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.